Aktie A3EW0P AETHLON MEDICAL, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Aethlon Medical, Inc.

Aktien

A3EW0P

US00808Y4061

AEMD

Verzögert Nasdaq
Andere Börsenplätze
 15:52:30 24.04.2024 		% 5 Tage % 1. Jan.
1,51 USD -0,13 % Intraday Chart für Aethlon Medical, Inc. +6,34 % -31,05 %
14.02. Aethlon Medical, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI
14.02. Transcript : Aethlon Medical, Inc., Q3 2024 Earnings Call, Feb 14, 2024

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer
Aethlon Medical, Inc Announces Executive Changes
Aethlon Medical, Inc. Announces Appointment Ofguy Ciprian as Chief Operating Officer
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023
Aethlon Medical, Inc. Receives Clearance from Drug Controller General of India for Potential Phase 1 Trial of its Hemopurifier(R) in Oncology
Aethlon Medical Board Approves 1-for-10 Reverse Stock Split
Aethlon Announces Reverse Stock Split
Aethlon Medical : September 2023 Aethlon Presentation for HC Wainwright Financial Conference
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023
Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant
Aethlon Medical, Inc. Appoints Nicolas Gikakis as Member of the Board and Member of the Nominating Committee
Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EW0P Aktie
  4. Nachrichten Aethlon Medical, Inc.
  5. Andere Sprachen